Certain Common Stock of Revance Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2016. These Common Stock will be under lockup for 60 days starting from 3-NOV-2015 to 2-JAN-2016.

Details:
The directors, officers, including Dr. Bertolino, and certain of stockholders have agreed that for a period of 60 days from the date of the prospectus that they will not dispose of or hedge any shares or any securities convertible into or exchangeable for common stock without the prior written consent of the Cowen and Company, LLC and Piper Jaffray & Co.